Background: Leishmania synthesize pyrimidine nucleotides via biosynthetic and salvage pathways. Results: Genetic blocks in pyrimidine biosynthesis and/or salvage can impact both life cycle stages of Leishmania. Conclusion: Pyrimidine biosynthesis and salvage both contribute to Leishmania homeostasis in animal infections. Significance: Functional characterization of pyrimidine pathways is crucial for understanding pyrimidine metabolism and validation of potential drug targets and vaccine strains.
and genetic investigations on the pyrimidine biosynthetic enzymes as well as the enzymes that salvage preformed pyrimidines from the host are virtually nonexistent at the molecular level for this genus. A schematic representation of the pyrimidine transport, biosynthesis, salvage, and interconversion pathways is depicted in Fig. 1 .
Aoki and co-workers (15) first noted that the genes encoding all six pyrimidine biosynthetic enzymes of Trypanosoma cruzi, another protozoan parasite and member of the Trypanosomatidae family, are syntenic in the genome of the parasite. Bioinformatic analysis of the annotated genomes of four Leishmania species as well as the genome of Trypanosoma brucei reveal a similar clustering of pyrimidine biosynthesis genes in all of these human pathogens (16 -19) . Limited in vitro studies on the pyrimidine biosynthetic pathway enzymes in cultured trypanosomatids have been performed. These include one report that implies that disruption of the dihydroorotate dehydrogenase (DHODH) genes that encode the fourth enzyme in the biosynthetic pathway in T. cruzi is a lethal event (20) and a similar analysis in T. brucei in which RNAi knockdown of DHODH restrained parasite growth in pyrimidine-deficient growth medium (21) . In addition, a recent article showed a modest (ϳ3-fold) growth inhibition of intracellular amastigotes upon genetic ablation of the CPS gene in T. cruzi (22) . However, in vivo evaluation of the relative contributions of trypanosomatid pyrimidine salvage and de novo synthesis pathways to parasite survival are lacking.
To initiate a dissection of the pyrimidine pathway in L. donovani, a species in which many functional studies on the purine pathway have been performed (23) (24) (25) (26) (27) (28) , the entire complement of L. donovani pyrimidine biosynthesis genes as well as the UPRT gene have been cloned, and their coding regions have been sequenced. Additionally, independent mutant L. donovani strains deficient either in the first enzyme in the biosynthetic pathway, CPS, in UPRT, or in both CPS and UPRT have been constructed using targeted gene replacement strategies. Cultured promastigotes of the ⌬cps and ⌬cps/⌬uprt lines exhibited a conditionally lethal growth phenotype because viability and sustained proliferation required the provision of an exogenous source of pyrimidine in the culture medium. The ⌬cps null mutant remained capable of establishing an infection in susceptible BALB/c mice, indicating that the intracellular L. donovani amastigote within the mammalian macrophage phagolysosome has access to a salvageable pyrimidine pool. The ⌬uprt knockout was prototrophic for pyrimidines but was incapable of incorporating either uracil or uridine into its nucleotide pools, establishing UPRT as the focal enzyme within the pyrimidine salvage pathway in L. donovani. The ⌬cps/⌬uprt double knockout, however, was fully attenuated with no persistent parasites observed 4 weeks postinoculation. These findings intimate that an effective therapeutic strategy targeting the pyrimidine pathway will require simultaneous inhibition of both pyrimidine biosynthesis and salvage and reinforce the potential for using the ⌬cps/⌬uprt line as a live attenuated vaccine for visceral leishmaniasis prevention.
EXPERIMENTAL PROCEDURES
Materials, Chemicals, and Reagents- [5,6- 3 H]Uracil (38 Ci/mmol) and [5,6- 3 H]uridine (43.6 Ci/mmol) were purchased from Moravek Biochemicals (Brea, CA), and [ 32 P]dCTP (3000 Ci/mmol) was obtained from MP Biomedicals (Irvine, CA). Unlabeled pyrimidine bases and nucleosides were obtained from Sigma-Aldrich and Fisher. All restriction and DNA-modifying enzymes were acquired from either Invitrogen or New England Biolabs, Inc. (Beverly, MA). Synthetic oligonucleotides were purchased from Integrated DNA Technologies, Inc. (Coralville, IA) or Invitrogen. PfuTurbo high fidelity DNA polymerase (Agilent Technologies Co., Santa Clara, CA) was employed for all PCR amplifications of DNA sequences. The transfection vectors pX63-HYG (29), pX63-PHLEO (30) , and pXG-NEO (31) were generously furnished by Dr. Stephen M. Beverley (Washington University, St. Louis, MO). Hygromycin was procured from Roche Applied Science, and phleomycin was from Research Products International (Mt. Prospect, IL), blasticidin was from Fisher, G418 was from BioWhittaker (Walkersville, MD), and puromycin and FBS were from Sigma-Aldrich. All other chemicals and reagents were of the highest quality commercially available.
Parasite Cell Culture-The wild type LdBob L. donovani clone (32) was obtained from Dr. Stephen M. Beverley. LdBob is derived from the 1S2D strain (33, 34) , which had been acclimated for growth as axenic amastigotes (32, 35) . Promastigotes were cultured at 26°C in pH 7.4 DME-L medium that was supplemented with 10% FBS and 100 M hypoxanthine (36) . Parasite lines that were auxotrophic for pyrimidines were routinely maintained in medium supplemented with 250 M uridine or, when necessary to bypass a concomitant deficiency in pyrimidine salvage, 2 mM orotate. For the investigation of parasite growth in exogenous pyrimidine sources and for the incorporation of [5,6- 3 H]uracil and [5, H]uridine, the medium was supplemented with 10% Serum Plus (SAFC Biosciences, Lenexa, KS) instead of FBS. Serum Plus lacks the residual pyrimidines found in FBS that would interfere with the assay. The single-cell cloning protocols for L. donovani promastigotes FIGURE 1. Schematic of pyrimidine metabolism in L. donovani. The double curved line represents the parasite plasma membrane, whereas arrows indicate the biochemical function or transport activity of the following: CPS (1), ACT (2), DHO (3), DHODH (4), UMPS (5 and 6), nucleoside transporter 1 (7), uracil transporter (8) , cytidine deaminase (9); uridine phosphorylase (10), nucleoside hydrolase (11) , and UPRT (12) .
employed in this investigation were originally described by Iovannisci and Ullman (37) .
Parasite Growth-The abilities of wild type, ⌬cps, and ⌬cps/ ⌬uprt parasites to proliferate in various pyrimidine sources were determined by placing 5.0 ϫ 10 3 parasites into individual wells of a 96-well cell culture plate containing 0.2 ml of growth medium supplemented with either a 100 M, 500 M, or 2 mM concentration of the appropriate pyrimidine. Wells lacking pyrimidine supplement were included as controls. Uracil growth inhibition experiments were conducted using the same protocol but as a function of multiple uracil concentrations. At the end of each growth experiment, parasites were enumerated using the vital dye alamarBlue TM (BIOSOURCE) technology (38) . Reduction of alamarBlue TM was monitored at 570 and 600 nm on a Multiskan Ascent plate reader (Thermo Labsystems, Vaantaa, Finland). The percentage of dye reduction was calculated according to the formula outlined in the manufacturer's brochure. The greatest reduction was expressed as maximal proliferation.
To determine parasite growth rates, promastigotes were initially seeded at a concentration of 1 ϫ 10 6 parasites/ml in 10 ml of permissive medium (DME-L medium containing 10% FBS, 100 M hypoxanthine, and either 250 M cytidine for ⌬cps mutants or 2 mM orotate for ⌬cps/⌬uprt mutants). Cultures were incubated overnight to attain logarithmic growth and were used to inoculate new cultures at 1 ϫ 10 6 parasites/ml in 10 ml of similar permissive medium. The parasite densities were enumerated by a hemacytometer every 8 -16 h over a 48-h period. The effect of uracil concentration on the growth rate of ⌬cps promastigotes was ascertained using the identical protocol except that once logarithmic growth was achieved, parasites were seeded at a density 1 ϫ 10 6 in 5 ml of DME-L medium that was supplemented with either 100 M, 500 M, 2 mM, or 4 mM uracil. Parasite densities were determined by hemacytometer in 8 -24-h intervals over 10 days.
Molecular Cloning of CPS and UPRT-Because of the synteny of pyrimidine biosynthesis genes in trypanosomatids (15) (16) (17) (18) (19) , the entire pyrimidine biosynthesis gene cluster from L. donovani was isolated using DNA probes corresponding to coding regions from both the CPS and DHODH genes from L. major, which correspond to the 5Ј-and 3Ј-ends of the syntenic region (16) . The CPS (LmjF16.0590) and DHODH (LmjF16.0530) sequences were amplified from L. major genomic DNA via PCR using the primers depicted in supplemental Table S1 and cloned into the pCR 2.1-TOPO vector of the TOPO TA Cloning TM kit (Invitrogen). The LmCPS probe fragment was then used to screen an L. donovani cosmid library using high stringency conditions. Twenty positive cosmid clones were pooled and plated for a secondary screen with the LmDHODH probe to allow isolation of cosmids containing the full pyrimidine biosynthesis locus. Cosmid DNA was purified by conventional methods from a cosmid that hybridized to both probes. The genes encoding CPS (JN882600), DHODH (JQ436846), aspartate carbamoyltransferase (ACT) (JQ436847), dihydroorotase (DHO) (JQ436845), and the bifunctional UMP synthase (UMPS) protein (JN882599) that catalyzes the last two steps in de novo pyrimidine biosynthesis were then sequenced bidirectionally using automated sequencing available at the Oregon Health and Science University, and the sequences deposited in GenBank TM (accession numbers shown in parentheses).
The CPS ORF was amplified from cosmid DNA by PCR using the primers depicted in supplemental Table S1 and directionally cloned into the pET200/D-TOPO Escherichia coli expression vector (Invitrogen), which automatically tags encoded proteins with an amino-terminal His 6 tag. Similarly, the UPRT ORF was cloned into the pET200/D-TOPO expression vector following PCR amplification using primers (see supplemental  Table S1 ) designed to the UPRT sequence provided in the annotated genome sequence of Leishmania infantum (16) , a species closely related to L. donovani. The cloned UPRT gene from vectors derived from three independent PCRs was sequenced using vector-specific primers, and the sequence was deposited in GenBank (JN882601).
Creation of Constructs for CPS Gene Replacement-The 5Ј-and 3Ј-sequences flanking the CPS ORF were identified and sequenced from the cosmid DNA. To construct gene targeting cassettes to replace both CPS alleles, ϳ600 bp of 5Ј-and 3Ј-flanking regions were amplified by PCR and subcloned sequentially into the HindIII/SalI or BamHI sites, respectively, of the pX63-HYG (29) and pX63-PHLEO (30) plasmids. An additional HindIII site was included in the reverse primer for the 3Ј-targeting sequence to facilitate excision of the targeting cassette (supplemental Tables S1 and S2) .
Creation of Constructs for UPRT Gene Replacement-Targeting constructs for the replacement of UPRT via homologous recombination were generated according to the multifragment ligation method of Fulwiler et al. (39) . The 5Ј-and 3Ј-UPRT targeting sequence primers (supplemental Table S1 ) encoded SfiI restriction sites that provided unique overhangs upon SfiI digestion, facilitating simultaneous and ordered targeting vector assembly. UPRT targeting vectors that encoded expression cassettes conferring resistance to hygromycin or G418 were designated pTRG-HYG-⌬uprt and pTRG-NEO-⌬uprt, respectively (39) . An additional targeting construct, pTRG-bsd⌬uprt, encoded a blasticidin S deaminase gene (bsd), which relied upon the UPRT gene flanking sequences to provide the appropriate pre-mRNA processing signals for expression of blasticidin resistance.
Construction of CPS and UPRT Complementation VectorsThe CPS and UPRT ORFs with vector-encoded His 6 tags were excised from pET200-CPS or pET200-UPRT expression vectors (described above) with NdeI and BspEI and inserted into the corresponding sites of pXG-NEO-HA, a derivative of pXG-NEO into which a human influenza HA epitope tag and additional restriction sites had been incorporated to allow the generation of NH 2 -terminal HA tag protein fusions. 3 The CPS and UPRT sequences in these vectors, designated pXG-NEO-CPS and pXG-NEO-UPRT, respectively, encoded both HA and His 6 tags at the NH 2 terminus.
To generate complementation vectors with drug resistance markers compatible with the ⌬cps/⌬uprt null strain, the CPS and UPRT ORFs were excised from pXG-NEO-CPS or pXG-NEO-UPRT vectors with AvrII and XbaI and inserted into pRP-M-PAC, yielding pRP-M-PAC-CPS and pRP-M-PAC-UPRT, which confer puromycin resistance. The pRP-M vector expresses transgenes from the ribosomal RNA (RRNA) promoter upon integration into the RRNA array and has been used for complementation of ⌬umps parasites (40) .
Creation of Transgenic L. donovani-A summary of the gene targeting strategy is provided in supplemental Table S2 . For generation of the ⌬cps null strains from wild type L. donovani, the pX63-PHLEO-⌬cps and pX63-HYG-⌬cps vectors were digested with HindIII, and the targeting cassettes were gel-purified and then transfected using a GenePulser XCell (Bio-Rad) apparatus and the electroporation parameters originally reported previously (41) . Following transfection of wild type LdBob promastigotes with the PHLEO targeting cassette, heterozygous CPS/cps clones were selected on semisolid medium containing 50 g/ml phleomycin. Confirmed CPS/cps heterozygote clones were subsequently transfected with the HYG targeting cassette and selected on semisolid medium supplemented with 50 g/ml hygromycin and 50 g/ml phleomycin to select for homozygous ⌬cps knockouts and 500 M each uracil, uridine, and orotate to allow for growth via salvage of exogenous pyrimidines (supplemental Table S2 ).
The ⌬uprt and ⌬cps/⌬uprt null strains were created in both wild type and ⌬cps L. donovani following methods similar to those delineated above. All pTRG-⌬uprt vectors were digested with PacI to liberate the targeting cassettes containing the UPRT flanking regions. The targeting fragments were gel-purified and transfected into either wild type or ⌬cps parasites as indicated in supplemental Table S2 . Clonal ⌬uprt or ⌬cps/ ⌬uprt knockouts were then created in UPRT/uprt heterozygotes by a second round of transfection with the appropriate ⌬uprt targeting cassette and selection on medium containing 25 g/ml blasticidin and either 50 g/ml hygromycin (⌬uprt) or 20 g/ml G418 (⌬cps/⌬uprt). Orotate (2 mM) was used as the pyrimidine source in the selections for both the ⌬cps/UPRT/ uprt and ⌬cps/⌬uprt transgenic lines to enable pyrimidine salvage by a UPRT-independent route (i.e. through orotate phosphoribosyltransferase, part of the UMPS bifunctional protein).
The genetic deficiencies of the ⌬cps and ⌬cps/⌬uprt knockouts were complemented via episomal or integrating constructs, respectively, expressing either CPS or UPRT (supplemental Table S2 ). The ⌬cps line was transfected with pXG-NEO-CPS and selected in medium containing 20 g/ml G418. Because ⌬cps/⌬uprt clones contained drug resistance markers for hygromycin, phleomycin, blasticidin, and G418, integrating CPS (pRP-M-PAC-CPS) and UPRT (pRP-M-PAC-UPRT) vectors conferring puromycin resistance, were used for complementation. The vectors were linearized via AvrII digestion prior to transfection into ⌬cps/⌬uprt null strains and selection in DME-L medium containing 50 M puromycin. The CPS "add-back" cell lines were designated ⌬cps[pCPS] and ⌬cps/ ⌬uprt[RP-CPS], and UPRT add-back clones were designated ⌬cps/⌬uprt[RP-UPRT].
Uracil Incorporation Assays-The rates by which wild type or ⌬uprt promastigotes incorporated [5,6- 3 H]uracil or [5, H]uridine into their pyrimidine nucleotide pools were determined via a DE81 filter binding assay adapted from Ref. 27 . Cultures of exponentially growing wild type and ⌬uprt promastigotes were diluted to a final concentration of 1 ϫ 10 6 cells/ml into medium supplemented with Serum Plus and incubated at 26°C for 24 h. Parasites were pelleted by centrifugation, rinsed twice with PBS, and resuspended at a concentration of 5 ϫ 10 7 cells/ml in medium lacking pyrimidines. 1.0 ml of cell suspension was aliquoted into wells of a 24-well tissue culture plate, and the incorporation reaction was initiated by the addition of 26.3 pmol of [5,6- 3 H]uracil (38 Ci/mmol) or 22.9 pmol of [5, H]uridine (43.6 Ci/mmol) to each well. Plates were incubated at room temperature for the duration of the experiment. At various time points, 100 l of cell suspension was pipetted onto individual DE81 filter discs, and the discs were placed on two layers of Whatman 3MM chromatography paper (Whatman International, Ltd., Maidstone, UK) presoaked with lysis buffer consisting of 1% Triton X-100 and 2 mM uracil to quench the reaction. The filters were washed three times in 1,500 ml of distilled H 2 O for 3 min each to remove unincorporated [5,6- 3 H]uracil or [5, H]uridine, rinsed once in 95% ethanol, and dried at 60°C for 5 min. The dried filters were placed in scintillation vials with 3 ml of EcoLume scintillent (MP Biomedicals), and the extent of 3 H incorporation was assessed with a Beckman LS 6500 scintillation counter.
Mouse Infections-Groups of three or five 6 -7-week-old female BALB/c mice (Charles River Laboratories, Wilmington, MA) were each inoculated via tail vein injection with 5 ϫ (35) to revitalize ancillary virulence determinants that might have attenuated as a result of prolonged in vitro culture. One or 4 weeks postinfection, mice were sacrificed, and their livers and spleens were harvested (42) . Single-cell suspensions from the mouse organs were prepared by sieving through a 70-m cell strainer (BD Falcon, Franklin Lakes, NJ), and parasite loads were determined in 96-well microtiter plates using the limiting dilution assay of Buffet et al. (43) . The DME-L growth medium in which the organ-derived wild type, ⌬cps, ⌬uprt, ⌬cps/⌬uprt, ⌬cps [pCPS] , ⌬cps/ ⌬uprt[RP-CPS], and ⌬cps/⌬uprt[RP-UPRT] parasites were titered was supplemented with a permissive pyrimidine source as needed as well as with 100 M hypoxanthine and 10% FBS.
Macrophage Infections-Mouse peritoneal macrophages were harvested as described (42) . Bulk cultures of wild type and ⌬cps/⌬uprt promastigotes were allowed to grow to early stationary phase, washed two times in PBS, and resuspended in DME-L medium supplemented with 10% FBS. Mouse peritoneal macrophages were seeded into 4-well Lab-TekII chamber slides (Nalge Nunc International Corp., Naperville, IL) at a density of 2 ϫ 10 5 cells in 1.0 ml of Dulbecco's modified Eagle's medium supplemented with 10% FBS, 4 mM L-glutamine, 1.5 mg/ml sodium bicarbonate, and 4.5 mg/ml glucose and incubated at 37°C in a humidified 5% CO 2 incubator for 16 h. Adherent macrophages were incubated with 2.0 ϫ 10 6 stationary phase promastigotes of each strain for 6 h, after which the chambers were rinsed 10 times in PBS to remove residual extracellular promastigotes. The macrophages and parasites were immediately fixed and stained with the Diff-Quik kit (Interna-tional Medical Equipment Inc., San Marcos, CA), and images were captured with a Zeiss AxioCam MRm camera coupled to a Zeiss Axiovert 200 M scope (Carl Zeiss Microimaging, Thornwood, NY) using a ϫ60 oil immersion objective to allow visual enumeration of parasite-infected macrophages.
RESULTS

Isolation of L. donovani Pyrimidine Gene
Cluster-The L. donovani CPS was isolated from a cosmid library as part of a strategy to isolate the entire complement of pyrimidine biosynthesis genes. Given that the genes encoding the biosynthetic pathway are known to be colocalized on the genomes of T. cruzi, T. brucei, L. major, L. mexicana, and L. infantum trypanosomatids (15) (16) (17) (18) (19) , sequences within the 5Ј-and 3Ј-ORFs of the L. major cluster, CPS and DHODH, respectively, were amplified by PCR from L. major genomic DNA, and each was used to probe replica filters containing DNAs from an L. donovani cosmid library. Several cosmids that accommodated the entire ensemble of pyrimidine biosynthesis genes were obtained, and the ORFs of CPS, ACT, DHO, DHODH, and UMPS were sequenced. The L. donovani CPS is a polypeptide of 1,842 amino acids and, like the other trypanosomatid CPSs, is a bifunctional polypeptide that encodes an NH 2 -terminal glutamine amidotransferase domain that removes the amido nitrogen from glutamine to enable carbamoylphosphate synthesis from CO 2 . Unlike the mammalian enzyme (44, 45) , the trypanosomatid CPS proteins, including the L. donovani CPS, are not part of a trifunctional polypeptide encoding ACT and DHO. A multisequence alignment of the L. donovani, T. cruzi, human, and Saccharomyces cerevisiae CPS proteins is shown in supplemental Fig. S1A . The properties of the other L. donovani pyrimidine biosynthetic enzymes have been described (40) or will be described elsewhere.
Isolation of UPRT-The L. donovani UPRT gene was isolated from L. donovani genomic DNA via PCR using primers corresponding to the annotated UPRT genomic sequence from the closely related species L. infantum (16) . DNA sequencing revealed that L. donovani UPRT shares 100% identity at the nucleotide level to L. infantum UPRT. The L. donovani UPRT protein has been expressed in E. coli and purified to near homogeneity, and its activity as a uracil phosphoribosyltransferase has been confirmed. 4 A multisequence alignment of the UPRTs from L. donovani, Toxoplasma gondii, and S. cerevisiae is provided in supplemental Fig. S1B .
Creation of ⌬cps, ⌬uprt, and ⌬cps/⌬uprt Null Strains-⌬cps, ⌬uprt, and ⌬cps/⌬uprt mutants were created within LdBob, a strain of L. donovani capable of transformation into axenic amastigotes (32) , which retains its capacity to infect mammalian macrophages and to sustain a prolonged infection in susceptible mice (23, 42) . The CPS ORF was replaced by PHLEO or HYG drug resistance cassettes via double targeted gene replacement. The resulting ⌬cps null strains were selected on plates containing 500 M uracil, 500 M uridine, and 500 M orotate to circumvent potential pyrimidine auxotrophy. The correct allelic replacements at the CPS locus in the ⌬cps null mutants were confirmed by Southern blot analysis of genomic DNA probed with both the CPS ORF and its 5Ј-flank (Fig. 2, A  and B) .
The ⌬uprt and ⌬cps/⌬uprt null mutants were generated by replacing the UPRT gene from wild type and ⌬cps parasites, respectively, with compatible drug resistance markers. Although selection of ⌬uprt null mutants required no pyrimidine supplementation of the growth medium, selection of the ⌬cps/⌬uprt null mutants, which have lost the capacity for both de novo synthesis and normal salvage of pyrimidines, was absolutely dependent upon supplementation with 2 mM orotate. Orotate, an intermediate of de novo synthesis, is converted to UMP via UMPS and is thus capable of circumventing both the ⌬cps and ⌬uprt lesions. Southern blot analysis using the UPRT ORF and 3Ј-flank as hybridization probes confirmed deletion of the UPRT locus in both the ⌬uprt and ⌬cps/⌬uprt knockouts (Fig. 2, C and D) .
Pyrimidine Requirements of Mutant Parasites-After confirmation of the ⌬cps and ⌬uprt genotypes, the ⌬cps, ⌬uprt, and ⌬cps/⌬uprt mutants were tested for their abilities to grow in medium in the absence or presence of pyrimidine supplement. Although wild type L. donovani grew robustly in the absence of pyrimidines, both the ⌬cps single and ⌬cps/⌬uprt double knockouts were auxotrophic for pyrimidines and growth-arrested after 24 h in the absence of pyrimidine (Fig. 3, A-C) . That the pyrimidine auxotrophy of the ⌬cps and ⌬cps/⌬uprt strains was caused by the ⌬cps lesion was confirmed by the pyrimidine prototrophy of the ⌬cps[pCPS] and ⌬cps/⌬uprt[RP-CPS] addback lines (see "Experimental Procedures"). The ⌬uprt promastigotes, as expected, were also prototrophic for pyrimidines (see Fig. 4 ). The pyrimidine requirement conferred by the ⌬cps lesion was further evaluated as a function of the pyrimidine source and concentration (100 M, 500 M, and 2 mM). The ⌬cps single knockout exhibited robust growth at all three concentrations of uridine and deoxyuridine, at 500 M and 2 mM cytidine and deoxycytidine, at 2 mM orotate and dihydroorotate, and at 100 M uracil (Fig. 3B) . Maximum growth was not achieved at lower concentrations of cytidine, deoxycytidine, 4 D. R. Soysa and P. Yates, manuscript in preparation. orotate, or dihydroorotate, and interestingly, 500 M and 2 mM uracil proved inhibitory to ⌬cps proliferation. Cytosine, thymine, and thymidine were incapable of rescuing the ⌬cps knockouts at all concentrations tested (Fig. 3B) . Conversely, only 2 mM orotate and dihydroorotate were permissive for ⌬cps/⌬uprt growth, whereas uracil, cytosine, thymine, and their corresponding nucleosides were nonpermissive at all concentrations (Fig. 3C) . Complementation of the ⌬uprt lesion by UPRT in the ⌬cps/⌬uprt[RP-UPRT] mutant rescued the pyrimidine salvage defect enabling growth in all pyrimidine nucleobases and nucleosides that rescued the ⌬cps parasites (data not shown). Under conditions permissive for maximum growth, the growth rates of wild type, ⌬cps, ⌬uprt, and ⌬cps/⌬uprt promastigotes were equivalent with doubling times of ϳ16 h (Fig.  4) . Lack of growth under all experimental conditions, except supplementation of ⌬cps growth medium with high uracil, could not be ascribed to toxicity triggered by the extracellular pyrimidine because the growth of wild type L. donovani under all growth conditions was unaffected by the addition of any source or concentration of pyrimidine to the medium (Fig. 3A) .
Growth Inhibition by Uracil as Consequence of Pyrimidine Auxotrophy-The exclusive growth-inhibitory effect of uracil observed with ⌬cps promastigotes was unanticipated and was therefore examined in more detail as a function of a wide (3 M to 4 mM) range of uracil concentrations in the culture medium (Fig. 5A) . Maximum growth of the ⌬cps knockout was achieved in medium supplemented with ϳ16 M uracil. However, growth of ⌬cps promastigotes was inhibited at concentrations of uracil of Ͼ125 M, and essentially no growth was observed by 2 mM (Fig. 5A) . A similar pattern of uracil-mediated growth inhibition was observed in a previously isolated pyrimidine auxotroph deficient in UMP synthase (⌬umps) (40) , whereas wild type promastigotes were impervious to the uracil concentration in the culture medium. To distinguish whether the effects of uracil on ⌬cps promastigotes were growth-inhibitory or cytotoxic, doubling times of the pyrimidine auxotroph at a range of uracil concentrations were determined. Doubling times of exponentially growing ⌬cps promastigotes (0 -48 h) were determined to be ϳ12, ϳ17, ϳ26, and ϳ40 h for uracil concentrations of 100 M, 500 M, 2 mM, and 4 mM, respectively (Fig. 5B) . Eventually, ⌬cps promastigotes reached a maximum cell density of ϳ6 ϫ 10 7 cells/ml in 100 M and 500 M uracil and peaked at ϳ2 ϫ 10 7 cells/ml in 2 and 4 mM uracil after 10 days of growth (data not shown).
Uracil and Uridine Incorporation into Phosphorylated Metabolites-The availability of the ⌬uprt mutant and the requirement of ⌬cps promastigotes for exogenous pyrimidines afforded an opportunity to dissect the routes of pyrimidine salvage in L. donovani. Incorporation of [5,6- 3 H]uracil or [5, H]uridine by wild type parasites into phosphorylated anionic metabolites was linear for the duration of the 1-h experiment ( Fig. 6) . No radiolabel incorporation was observed into ⌬uprt promastigotes for either the nucleobase or nucleoside (Fig. 6) , implicating UPRT as the central pyrimidine salvage enzyme.
Impact of Genetic Defects in Pyrimidine Metabolism on Infectivity in Mice-
To determine the effects of genetic deficiencies in pyrimidine biosynthesis and salvage on the ability of L. donovani to establish a visceral infection in mice, parasite burdens in livers and spleens were determined after a 4-week infection with either wild type, null, or add-back parasites. Because of the labor-intensive nature of these mouse infectivity tests, the infectivity assessments of all of the cell lines were performed in separate experiments (Fig. 7) . In the first experimental prototype, liver and spleen parasitemias were established for wild type, ⌬cps, and ⌬cps[pCPS] parasites (Fig. 7A) . In these tests of infectivity, the overall parasite loads were reduced by approximately 2 orders of magnitude in mice infected with ⌬cps parasites compared with animals injected with the wild type L. donovani counterpart (Fig. 7A) . The parasitemia deficit triggered by the ⌬cps lesion was rescued by episomal complementation of the null mutation because parasite burdens in livers and spleens were effectively equivalent in mice infected with wild type or ⌬cps[pCPS] promastigotes. Liver parasite loads were slightly higher in mice injected with ⌬cps[pCPS] add-back promastigotes compared with those injected with wild type parasites. Although interruption of pyrimidine biosynthesis partially compromised the infectivity phenotype of L. donovani, ablation of pyrimidine salvage did not impact parasite loads of L. donovani because equivalent numbers of parasites were recovered from livers and spleens of mice inoculated with either wild type or ⌬uprt parasites (Fig. 7B) . Genetic obliteration of both pyrimidine biosynthesis and salvage, however, profoundly compromised the capacity of L. donovani to maintain an infection in mice (Fig. 7B) . Indeed, no parasites emerged from 4-week mouse infections with ⌬cps/⌬uprt parasites even when single-cell suspensions were prepared from entire livers and spleens of mice inoculated with the double knockout line. Complementation of either the biosynthetic or salvage pathway lesions in the ⌬cps/⌬uprt line re-established infectivity in a predictable fashion (Fig. 7B) . Parasite burdens of mice infected with ⌬cps/⌬uprt[RP-CPS] parasites were slightly greater in livers and equivalent in spleens to those observed for mice injected with wild type L. donovani, whereas parasitemias of mice inoculated with stationary phase ⌬cps/⌬uprt[RP-UPRT] promastigotes were 2 orders of magnitude lower than those of mice harboring wild type parasites (Fig. 7B) .
Short Term Macrophage and Mouse Infections with ⌬cps/ ⌬uprt Parasites-To examine whether the lack of persistent parasites in mice injected with a ⌬cps/⌬uprt inoculum was due to an inability to infect macrophages, wild type and ⌬cps/⌬uprt parasites were incubated with mouse peritoneal macrophages for 6 h, after which intracellular amastigotes were enumerated. This short term infection experiment in vitro revealed that ⌬cps/⌬uprt parasites were capable of entering macrophages and were able to initiate conversion to amastigotes at a rate similar to that of wild type parasites (Fig. 8, A and B) . To evaluate the hypothesis that ⌬cps/⌬uprt parasites are capable of infecting but not persisting in mice through a full 4-week infection, the number of tissue-derived amastigotes after a 1-week infection of BALB/c mice with ⌬cps/⌬uprt parasites was also determined. Although the parasite loads of livers and spleens harvested from mice inoculated with ⌬cps/⌬uprt were markedly reduced over those of mice infected with wild type parasites, persistent parasites could still be identified in these short term mouse infections (Fig. 8C) .
DISCUSSION
Unlike the purine salvage pathway, which serves as the sole mechanism by which protozoan parasites of humans manufacture purine nucleotides, Leishmania synthesize pyrimidine nucleotides via both biosynthesis from amino acids and onecarbon compounds and via salvage of preformed host pyrimidine bases and nucleosides (1) . This pyrimidine prototrophy is observed among all trypanosomatid parasites that infect humans, although several genera of protozoan parasites lack pyrimidine biosynthetic capacity (1). The relative contributions of pyrimidine biosynthesis and salvage to survival, growth, and infectivity of Leishmania parasites, however, have not been evaluated previously. In order to test the functional roles and contributions of the biosynthetic and salvage pathways to pyrimidine homeostasis in L. donovani, ⌬cps, ⌬uprt, and ⌬cps/ ⌬uprt mutants were created by double targeted gene replacement strategies. The consequent pyrimidine auxotrophy and conditionally lethal growth phenotype of the ⌬cps single knockout (Fig. 3B) indicate that the pyrimidine biosynthetic pathway FIGURE 5 . Uracil hypersensitivity in de novo pyrimidine biosynthesis mutants. A, wild type (f), ⌬cps (‚), and ⌬umps (E) promastigotes were tested for their ability to grow in media supplemented with various concentrations of uracil. The growth of wild type and mutant promastigotes in each concentration of uracil was normalized to the maximum growth achieved within the assay by that cell line and is represented as the percentage of maximum growth. B, growth rates of ⌬cps promastigotes in media supplemented with various concentrations of uracil. Logarithmic phase promastigotes were seeded a density of 1 ϫ 10 6 parasites/ml in medium containing either 100 M (OE), 500 M (), 2 mM (‚), or 4 mM (ƒ) uracil, and growth of the culture was determined as in Fig. 4 . Results depicted are the averages and S.E. (error bars) of three technical replicates.
is essential to the promastigote stage of L. donovani under the experimentally delimited laboratory conditions under which these experiments were carried out. Restoration of pyrimidine prototrophy in both the ⌬cps[pCPS] and ⌬cps/⌬uprt[RP-CPS] add-back lines proved that the ⌬cps auxtrophic phenotype is due to the genetic defect and not to some secondary genetic modification. Whether the conditionally lethal phenotype of the ⌬cps null mutant would affect survival, growth, and development in the insect vector under field conditions is, of course, unknown and depends upon the pyrimidine content of the insect milieu in which the promastigote subsists.
The pyrimidine auxotrophy induced by the ⌬cps lesion in L. donovani could be circumvented by micromolar concentrations of uracil, uridine, cytidine, and their deoxyribonucleoside counterparts. Dihydroorotate and orotate could also bypass a ⌬cps mutation but only at millimolar concentrations (Fig. 3B) . The discrepancies in the concentrations of dihydroorotate and orotate and other pyrimidines required to rescue the conditionally lethal ⌬cps growth phenotype can be ascribed to permeability differences, because dihydroorotate and orotate are both negatively charged, or to variations in the rate by which orotate and uracil are incorporated into nucleotides via orotate phosphoribosyltransferase and UPRT, respectively (see Fig. 1 ). Thymidine, thymine, and cytosine did not rescue the auxotrophy of the ⌬cps strain because the deoxyribonucleoside cannot meet the parasite's requirement for ribonucleotides, and the two nucleobases are not actively transported (5) and cannot be phosphoribosylated to the nucleotide level. Because the genomes of Leishmania species encode UPRT, uridine hydrolases, uridine phosphorylase, and cytidine deaminase, it is reasonable to infer that cytidine and deoxycytidine are deaminated to their uridine and deoxyuridine counterparts, respectively, uridine and deoxyuridine are cleaved to uracil, and uracil is phosphoribosylated via UPRT and incorporated into the parasite pyrimidine nucleotide pool (see Fig. 1 ). However, leishmanial genomes accommodate a homolog to the mammalian uridine-cytidine kinase, but most of these sequences bear frameshift mutations that disintegrate the open reading frame, implying that they are pseudogenes (19) . The inference that all pyrimidine salvage is funneled through UPRT was substantiated genetically because the pyrimidine auxotrophy of the ⌬cps/⌬uprt double knockout could not be circumvented with uracil, uridine, deoxyuridine, cytidine, or deoxycytidine (Fig.  3C) . Furthermore, ⌬uprt promastigotes cannot incorporate radiolabeled uracil or uridine into nucleotides (Fig. 6) , demonstrating that the uridine kinase homolog in the L. donovani genome is vestigial. Thus, UPRT is the only route by which uracil and preformed pyrimidine nucleosides can be salvaged by L. donovani, although high concentrations of exogenous dihydroorotate and orotate can be incorporated into UMP by the de novo pathway enabling the selection and survival of the ⌬cps/⌬uprt double knockout (see Fig. 1 ).
The collateral supersensitivity of the ⌬cps null mutant to exogenous uracil is intriguing, especially because the nucleobase is nontoxic to wild type cells (Figs. 3A and 5A ). This unusual growth susceptibility is specific to the nucleobase and not observed when ⌬cps promastigotes are grown in medium supplemented with a pyrimidine ribonucleoside or deoxyribonucleoside. Episomal complementation of the ⌬cps mutant in the ⌬cps[pCPS] line resulted in abolition of the uracil sensitivity, proving that the unusual growth response to uracil is triggered by the genetic lesion (data not shown). An analogous genetic replacement of the gene copies encoding the fifth and sixth steps of the de novo pathway, UMPS, also sensitizes L. donovani promastigotes to millimolar concentrations of uracil, demonstrating that the growth vulnerability phenotype is not peculiar to the ⌬cps lesion but, rather, is a property common to mutants incapable of de novo pyrimidine biosynthesis. Intriguingly, a similar hypersensitivity to high uracil concentrations has been noted in T. cruzi (22) and T. gondii (47) upon genetic ablation of de novo pyrimidine biosynthesis, intimating a shared mechanism of growth inhibition.
Despite their pyrimidine auxotrophy, ⌬cps L. donovani are only partially attenuated in their capacity to establish visceral infections in mice (Fig. 7A) , indicating that pyrimidine salvage within the phagolysosome of the host macrophage is sufficient for amastigote survival and maintenance. Because uracil incorporation by mammalian cells is negligible (48, 49) , steady-state pools of uracil are presumed to be low. Thus, the immediate source of salvageable pyrimidines in the phagolysosome is most likely the nucleosides uridine and cytidine. Because these nucleosides are funneled through uracil in L. donovani, a conditionally lethal ⌬cps/⌬uprt double mutant is completely attenuated, and no persistence is observed in livers or spleens 4 weeks postinfection. The retention of virulence by ⌬cps L. donovani was unanticipated, especially considering that Fox and Bzik (47) have established that a ⌬cps mutant of T. gondii, another intracellular protozoan parasite that causes toxoplasmosis in humans, is effectively avirulent, not only in immunocompetent BALB/c mice but also in interferon-␥-deficient mice that cannot resist infection even by normally avirulent T. gondii strains (50) . The discrepancy in the virulence characteristics between ⌬cps L. donovani and ⌬cps T. gondii can be ascribed either to variations in the microenvironments of the macrophage lysosome and the parasitopherous vacuole in which L. donovani and T. gondii reside, respectively, or to dissimilarities in the complement or properties of pyrimidine salvage and interconversion enzymes expressed by the two parasites.
Although the intergenic regions of the pyrimidine biosynthesis locus of L. donovani were not sequenced in this study, all five genes were syntenic, as expected from the mapped pyrimidine loci of Leishmania species (19) and T. cruzi (15) , because they were physically co-localized to a single cosmid DNA. T. brucei, however, exhibits a loss of synteny at the DHO locus (16). To our knowledge, the pyrimidine biosynthetic pathway genes represent the only example of microsyntenic clustering of an entire biosynthetic pathway in trypanosomatids. Conversely, UPRT as well as the pyrimidine nucleoside interconversion enzymes are non-syntenic with the biosynthetic cluster and with each other. Furthermore, our limited analysis revealed that CPS and DHODH were located at the 5Ј-and 3Ј-ends, respectively, of the pyrimidine biosynthesis locus, similar to other Leishmania species and T. cruzi, whose genomes have been sequenced, sug-FIGURE 8. Short term in vitro and in vivo infections with wild type and ⌬cps/⌬uprt parasites. A, images of stained murine macrophages after 6 h of infection with either wild type or ⌬cps/⌬uprt parasites. The arrows indicate intracellular amastigotes. Amastigotes within infected macrophages in 50 fields of view were enumerated visually, and the average number of parasites per infected macrophage is depicted in B. C, groups of three BALB/c mice were inoculated with either wild type or ⌬cps/⌬uprt parasites as described in the legend to Fig. 7 . After 1 week, the liver and spleen of each mouse was harvested, and the parasitemias in the livers (black bars) and spleens (gray bars) were determined via a limiting dilution assay. Error bars, S.E.
gesting shared synteny of the entire locus. Bioinformatic analysis also revealed the presence of a gene encoding a hypothetical protein and several histone genes within the pyrimidine clusters of L. major, L. mexicana, and L. infantum (19) . Whether other essential genes have integrated into the pyrimidine gene cluster in L. donovani is currently being investigated via attempts to delete the entire complement of pyrimidine biosynthesis enzymes by targeted gene replacement.
The L. donovani CPS protein displays the same structural features described by Aoki and co-workers (3, 15) for the CPS proteins from Crithidia fasciculata, L. mexicana, and T. cruzi. Several of these shared features distinguish the L. donovani and other trypanosomatid CPS proteins from their mammalian and prokaryotic counterparts. In contrast to prokaryotes, where glutamine amidotransferase and CPS activities are found as distinct polypeptides, the L. donovani CPS accommodates an NH 2 -terminal glutamine amidotransferase domain separated by a short polylinker region from the catalytic CPS domain. Moreover, the L. donovani CPS is a genetically and biochemically distinct protein from ACT and DHO, whereas these enzymatic activities are encoded as a single trifunctional polypeptide in mammalian cells (44, 45) as well as in Dictyostelium discoideum (51) and Drosophila melanogaster (52) . Other L. donovani pyrimidine biosynthesis enzymes also exhibit signature trypanosomatid distinctions from their mammalian counterparts, including (i) a bifunctional UMPS polypeptide in which the two distinct enzymatic entities are arranged in the reverse order of the bifunctional mammalian UMPS protein and that contains a COOH-terminal peroxisomal targeting signal (53, 54) that directs targeting of proteins to the glycosome, a unique microbody of trypanosomatids (55, 56) ; (ii) monofunctional ACT and DHO enzymes; and (iii) a DHODH that is analogous to the fumarate-dependent enzyme of T. brucei (20, 21) .
This investigation offers the first functional analysis of the pyrimidine biosynthetic and salvage pathways of Leishmania and delineates the relative contributions of the two pathways to pyrimidine homeostasis, both in vitro and in vivo. These data indicate that a lesion in the first enzyme of the de novo pathway is lethal to the promastigote under pyrimidine-free growth conditions, but this lethality can be circumvented by a battery of exogenous pyrimidines that are channeled through UPRT into the parasite pyrimidine nucleotide pool. Conversely, the L. donovani amastigote can avail itself of its pyrimidine salvage machinery in order to survive and proliferate in mice because a genetic block in CPS does not produce an attenuated phenotype, although total parasite burdens are somewhat reduced compared with mice inoculated with wild type parasites. Genetic obliteration of pyrimidine salvage in the ⌬cps genetic background results in a completely attenuated infectivity phenotype that can be genetically reversed by functional restoration of either the biosynthetic or salvage pathway. These data imply, therefore, that targeting the functionally redundant pyrimidine pathway of Leishmania with chemotherapeutics would require simultaneous inhibition of both biosynthesis and salvage. Furthermore, the lack of persistence of the ⌬cps/⌬uprt strain in mice after a 4-week infection could be advantageous in implementing a live attenuated parasite vaccination strategy for leishmaniasis, although low levels of persistence are thought to be necessary for producing T-cell protective immunity to subsequent challenge by Leishmania (46, 57, 58) . Whether ⌬cps/ ⌬uprt parasites persist or can be made to persist for a long enough time period to trigger long term protective immunity remains to be investigated.
